Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Molecular Therapy. Methods & Clinical Development
|
April 18, 2020
Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes
Seiji Kuroda, Yoshitaka Miyagawa, Yuriko Sato, et al.
Iscience
|
May 31, 2022
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy
Adrianne L Jenner, Munisha Smalley, David Goldman, et al.
Molecular Therapy Oncolytics
|
September 23, 2021
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
Joseph W Jackson, Bonnie L Hall, Marco Marzulli, et al.
Frontiers in Molecular Neuroscience
|
August 1, 2024
Disease-modifying rdHSV-CA8* non-opioid analgesic gene therapy treats chronic osteoarthritis pain by activating Kv7 voltage-gated potassium channels
Gerald Z Zhuang, William F Goins, Munal B Kandel, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 19, 2004
Delivery of herpes simplex virus-based vectors to stem cells
Darren Wolfe, James B Wechuck, David M Krisky, et al.
Neuroscience
|
September 25, 2017
Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury
Nobutaka Shimizu, Mark F Doyal, William F Goins, et al.
Neuroscience
|
April 29, 2018
Corrigendum to 'Morphological Changes in Different Populations of Bladder Afferent Neurons Detected by Herpes Simplex Virus (HSV) Vectors with Cell-type-specific Promoters in Mice with Spinal Cord Injury' [Neuroscience 364 (2017) 190-201]
Nobutaka Shimizu, Mark F Doyal, William F Goins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 18, 2010
HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation
James R Goss, Michael Cascio, William F Goins, et al.
Frontiers in Molecular Neuroscience
|
May 24, 2024
rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels
Munal B Kandel, Gerald Z Zhuang, William F Goins, et al.
The Journal of Urology
|
April 12, 2005
Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats
Nelson E Bennett, Jang H Kim, Darren P Wolfe, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Molecular Therapy. Methods & Clinical Development
|
April 18, 2020
Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes
Seiji Kuroda, Yoshitaka Miyagawa, Yuriko Sato, et al.
Iscience
|
May 31, 2022
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy
Adrianne L Jenner, Munisha Smalley, David Goldman, et al.
Molecular Therapy Oncolytics
|
September 23, 2021
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
Joseph W Jackson, Bonnie L Hall, Marco Marzulli, et al.
Frontiers in Molecular Neuroscience
|
August 1, 2024
Disease-modifying rdHSV-CA8* non-opioid analgesic gene therapy treats chronic osteoarthritis pain by activating Kv7 voltage-gated potassium channels
Gerald Z Zhuang, William F Goins, Munal B Kandel, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 19, 2004
Delivery of herpes simplex virus-based vectors to stem cells
Darren Wolfe, James B Wechuck, David M Krisky, et al.
Neuroscience
|
September 25, 2017
Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury
Nobutaka Shimizu, Mark F Doyal, William F Goins, et al.
Neuroscience
|
April 29, 2018
Corrigendum to 'Morphological Changes in Different Populations of Bladder Afferent Neurons Detected by Herpes Simplex Virus (HSV) Vectors with Cell-type-specific Promoters in Mice with Spinal Cord Injury' [Neuroscience 364 (2017) 190-201]
Nobutaka Shimizu, Mark F Doyal, William F Goins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 18, 2010
HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation
James R Goss, Michael Cascio, William F Goins, et al.
Frontiers in Molecular Neuroscience
|
May 24, 2024
rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels
Munal B Kandel, Gerald Z Zhuang, William F Goins, et al.
The Journal of Urology
|
April 12, 2005
Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats
Nelson E Bennett, Jang H Kim, Darren P Wolfe, et al.
Page
of 8